Form 4: Semler Scientific Director Eric Semler Exercises Stock Options, Increases Direct Holdings

Semler Scientific, Inc. Director Eric Semler exercised stock options to acquire 6,750 shares of common stock at $23.32 per share, increasing his direct beneficial ownership.

Summary

• Eric Semler, a Director of Semler Scientific, Inc. (SMLR), executed a transaction on June 11, 2025.
• The transaction involved the exercise of stock options (a derivative security) to acquire 6,750 shares of Semler Scientific common stock.
• The exercise price for these shares was $23.32 per share.
• Following this transaction, Mr. Semler directly beneficially owns 636,346 shares of Common Stock.
• Additionally, Mr. Semler indirectly beneficially owns 77,771 shares of Common Stock through TCS Capital Advisors, LLC, though he disclaims beneficial ownership except to the extent of his pecuniary interest.
• After the exercise, Mr. Semler still holds 20,250 unexercised stock options with an exercise price of $23.32, which vest monthly until April 24, 2026, and expire on May 24, 2026.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director generally indicates confidence in the company's future performance and valuation, as the insider is increasing their direct equity exposure.

Positives

• The exercise of stock options by a director indicates continued confidence in the company's future prospects and valuation at the exercise price.
• An increase in direct beneficial ownership by an insider can be viewed as a positive signal to the market regarding the company's outlook.

Future Outlook

The document primarily reports an insider transaction and does not provide explicit forward-looking statements or guidance on the company's financial performance or strategic direction, beyond the vesting schedule of the exercised options.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction and does not provide broader industry context or trends. It reflects an individual director's activity within the healthcare technology sector.

Stakeholder Impact

• Shareholders may interpret the director's option exercise as a positive signal, reflecting management's belief in the company's value and future growth.

Next Steps

• Remaining stock options held by Eric Semler will continue to vest monthly until April 24, 2026.

Key Dates

Keywords

Semler Scientific, SMLR, Insider Transaction, Form 4, Stock Option Exercise, Beneficial Ownership, Director Holdings, Equity Compensation